As per the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and all other applicable provisions and further to the outcome of meeting of the Board of Directors held on February 14, 2024, Natco Pharma has informed that it enclosed the Notice of Postal Ballot for seeking approval of Members for Appointment/ Re-appointment of Directors. Details enclosed.
The above information is a part of company’s filings submitted to BSE.